Asher MI, Montefort S, Björkstén B, Lai CKW, Strachan DP, Weiland SK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet. 2006;368(9537):733–43.
Keith PK, Desrosiers M, Laister T, Schellenberg RR, Waserman S. The burden of allergic rhinitis (AR) in canada: perspectives of physicians and patients. All Asth Clin Immun. 2012;8(1):1–11.
Wise SK, Lin SY, Toskala E, Orlandi RR, Akdis CA, Alt JA, et al. International consensus statement on allergy and rhinology: allergic rhinitis. Int Forum Allergy Rhinol. 2018;8(2):108–352.
PubMed PubMed Central Google Scholar
Turner H, Kinet JP. Signalling through the high-affinity IgE receptor Fc EpsilonRI. Nature. 1999;402(6760 Suppl):B24–30.
Davis A, Linton S, Hossenbaccus L, Thiele J, Botting H, Walker T, et al. Analyzing phenotypes post-exposure in allergic rhinitis in the environmental exposure unit. Ann Allergy Asthma Immunol. 2024;S1081–1206(24):01659–4.
Scadding GW, Eifan A, Penagos M, Dumitru A, Switzer A, McMahon O, et al. Local and systemic effects of Cat allergen nasal provocation. Clin Exp Allergy. 2015;45(3):613.
CAS PubMed PubMed Central Google Scholar
Thwaites RS, Gunawardana NC, Broich V, Mann EH, Ahnström J, Campbell GA, et al. Biphasic activation of complement and fibrinolysis during the human nasal allergic response. J Allergy Clin Immunol. 2018;141(5):1892–e18956.
PubMed PubMed Central Google Scholar
Naclerio RM, Meier HL, Kagey-Sobotka A, Adkinson NF, Meyers DA, Norman PS, et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis. 1983;128(4):597–602.
Creticos PS, Peters SP, Adkinson NF, Naclerio RM, Hayes EC, Norman PS, et al. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med. 1984;310(25):1626–30.
Bascom R, Pipkorn U, Proud D, Dunnette S, Gleich GJ, Lichtenstein LM, et al. Major basic protein and eosinophil-derived neurotoxin concentrations in nasal-lavage fluid after antigen challenge: effect of systemic corticosteroids and relationship to eosinophil influx. J Allergy Clin Immunol. 1989;84(3):338–46.
Miadonna A, Tedeschi A, Arnoux B, Sala A, Zanussi C, Benveniste J. Evidence of PAF-acether metabolic pathway activation in antigen challenge of upper respiratory airways. Am Rev Respir Dis. 1989;140(1):142–7.
Rawls M, Thiele J, Adams DE, Steacy LM, Ellis AK. Clinical symptoms and biomarkers of Bermuda grass-induced allergic rhinitis using the nasal allergen challenge model. Ann Allergy Asthma Immunol. 2020;124(6):608–e6152.
Soliman M, Steacy LM, Thiele J, Adams DE, Neighbour HL, Ellis AK. Repeatability of nasal allergen challenge results: further validation of the allergic rhinitis clinical investigator collaborative protocols. Ann Allergy Asthma Immunol. 2018;120(6):607–13.
Soliman M, Steacy L, Thiele J, Adams D, Neighbour H, Ellis AK. Administering multiple cumulative allergen challenges: an alternative nasal allergen challenge protocol for the allergic Rhinitis-Clinical investigator collaborative. Ann Allergy Asthma Immunol. 2016;117(3):326–8.
Thiele J, Soliman M, Steacy LM, Adams D, Ellis AK. The allergic rhinitis clinical investigator collaborative (AR-CIC) - Cytokine analysis of nasal secretions before and after nasal allergen challenges (NAC). J Allergy Clin Immunol. 2016;137(2):AB165.
Baumann R, Rabaszowski M, Stenin I, Tilgner L, Scheckenbach K, Wiltfang J, et al. Comparison of the nasal release of IL-4, IL-10, IL-17, CCL13/MCP-4, and CCL26/eotaxin-3 in allergic rhinitis during season and after allergen challenge. Am J Rhinol Allergy. 2013;27(4):266–72.
Baumann R, Rabaszowski M, Stenin I, Gaertner-Akerboom M, Scheckenbach K, Wiltfang J, et al. The release of IL-31 and IL-13 after nasal allergen challenge and their relation to nasal symptoms. Clin Transl Allergy. 2012;2:13.
CAS PubMed PubMed Central Google Scholar
Banfield G, Watanabe H, Scadding G, Jacobson MR, Till SJ, Hall DA, et al. CC chemokine receptor 4 (CCR4) in human allergen-induced late nasal responses. Allergy. 2010;65(9):1126–33.
Gosset P, Malaquin F, Delneste Y, Wallaert B, Capron A, Joseph M, et al. Interleukin-6 and interleukin-1 alpha production is associated with antigen-induced late nasal response. J Allergy Clin Immunol. 1993;92(6):878–90.
Sim TC, Grant JA, Hilsmeier KA, Fukuda Y, Alam R. Proinflammatory cytokines in nasal secretions of allergic subjects after antigen challenge. Am J Respir Crit Care Med. 1994;149(2 Pt 1):339–44.
König K, Klemens C, Eder K, San Nicoló M, Becker S, Kramer MF, et al. Cytokine profiles in nasal fluid of patients with seasonal or persistent allergic rhinitis. Allergy Asthma Clin Immunol. 2015;11(1):26.
PubMed PubMed Central Google Scholar
Scadding GW, Calderon MA, Bellido V, Koed GK, Nielsen NC, Lund K, et al. Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes. J Immunol Methods. 2012;384(1–2):25–32.
Orban NT, Jacobson MR, Nouri-Aria KT, Durham SR, Eifan AO. Repetitive nasal allergen challenge in allergic rhinitis: priming and Th2-type inflammation but no evidence of remodelling. Clin Exp Allergy. 2021;51(2):329–38.
Lim MC, Taylor RM, Naclerio RM. The histology of allergic rhinitis and its comparison to cellular changes in nasal lavage. Am J Respir Crit Care Med. 1995;151(1):136–44.
Thiele J, Adams D, Soliman M, Steacy L, Ellis A. Nasal allergen challenge (NAC) induced Eosinophilia - the allergic rhinitis clinical investigator collaborative (AR-CIC). J Allergy Clin Immunol. 2015;135(2):AB223.
Bascom R, Wachs M, Naclerio RM, Pipkorn U, Galli SJ, Lichtenstein LM. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol. 1988;81(3):580–9.
Leaker BR, Malkov VA, Mogg R, Ruddy MK, Nicholson GC, Tan AJ, et al. The nasal mucosal late allergic reaction to grass pollen involves type 2 inflammation (IL-5 and IL-13), the inflammasome (IL-1β), and complement. Mucosal Immunol. 2017;10(2):408–20.
Francis JN, Lloyd CM, Sabroe I, Durham SR, Till SJ. T lymphocytes expressing CCR3 are increased in allergic rhinitis compared with non-allergic controls and following allergen immunotherapy. Allergy. 2007;62(1):59–65.
Jahnsen FL, Lund-Johansen F, Dunne JF, Farkas L, Haye R, Brandtzaeg P. Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy. J Immunol. 2000;165(7):4062–8.
Pilette C, Jacobson MR, Ratajczak C, Detry B, Banfield G, VanSnick J, et al. Aberrant dendritic cell function conditions Th2-cell polarization in allergic rhinitis. Allergy. 2013;68(3):312–21.
Eguíluz-Gracia I, Bosco A, Dollner R, Melum GR, Lexberg MH, Jones AC, et al. Rapid recruitment of CD14(+) monocytes in experimentally induced allergic rhinitis in human subjects. J Allergy Clin Immunol. 2016;137(6):1872–e188112.
Dhariwal J, Cameron A, Trujillo-Torralbo MB, del Rosario A, Bakhsoliani E, Paulsen M, et al. Mucosal type 2 innate lymphoid cells are a key component of the allergic response to aeroallergens. Am J Respir Crit Care Med. 2017;195(12):1586–96.
CAS PubMed PubMed Central Google Scholar
Naclerio RM, Adkinson NF, Moylan B, Baroody FM, Proud D, Kagey-Sobotka A, et al. Nasal provocation with allergen induces a secondary serum IgE antibody response. J Allergy Clin Immunol. 1997;100(4):505–10.
Braunstahl GJ, Overbeek SE, Kleinjan A, Prins JB, Hoogsteden HC, Fokkens WJ. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol. 2001;107(3):469–76.
Doherty TA, Scott D, Walford HH, Khorram N, Lund S, Baum R, et al. Allergen challenge in allergic rhinitis rapidly induces increased peripheral blood type 2 innate lymphoid cells that express CD84. J Allergy Clin Immunol. 2014;133(4):1203–5.
CAS PubMed PubMed Central Google Scholar
Hossenbaccus L, Linton S, Thiele J, Steacy L, Walker T, Malone C et al. Biologic Responses to House Dust Mite Exposure in the Environmental Exposure Unit. Front Allergy. 2022 Jan 7 [cited 2024 Jul 19];2. Available from: https://www.frontiersin.org/journals/allergy/articles/https://doi.org/10.3389/falgy.2021.807208/full
Qi S, Barnig C, Charles AL, Poirot A, Meyer A, Clere-Jehl R, et al. Effect of nasal allergen challenge in allergic rhinitis on mitochondrial function of peripheral blood mononuclear cells. Ann Allergy Asthma Immunol. 2017;118(3):367–9.
Larson D, Patel P, Salapatek AM, Couroux P, Whitehouse D, Pina A, et al. Nasal allergen challenge and environmental exposure chamber challenge: A randomized trial comparing clinical and biological responses to Cat allergen. J Allergy Clin Immunol. 2020;145(6):1585–97.
Comments (0)